Sunday - November 15, 2026
Goodwin Advises Indivior Pharmaceuticals on Merger With Supernus Pharmaceuticals
November 02, 2026
BOSTON, Massachusetts, Nov. 2 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Advises Indivior Pharmaceuticals on Merger With Supernus Pharmaceuticals

*

The Life Sciences team guided Indivior Pharmaceuticals, Inc. ("Indivior") (Nasdaq: INDV) in its definitive agreement to combine with Supernus Pharmaceuticals, Inc. ("Supernus") (Nasdaq: SUPN) in a tax-free, all-stock merger o . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products